Last reviewed · How we verify

NCT03679065

Prophylactic Paracetamol or Dexamethasone for Post-spinal Anesthesia Shivering

Completed Phase 4 Last updated 20 September 2018
What this trial tests

Phase 4 trial testing Paracetamol in Shivering in 300 participants. Completed in 31 August 2018.

Timeline
1 March 2018
Primary endpoint
31 August 2018
31 August 2018

Quick facts

Lead sponsorAin Shams University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment300
Start date1 March 2018
Primary completion31 August 2018
Estimated completion31 August 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 60, any sex, with Shivering. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to evaluate the effects of a prophylactic dose of oral paracetamol on shivering compared with prophylactic intravenous infusion (IVI) dexamethasone in patients undergoing non-obstetric surgeries under spinal anesthesia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Postspinal anesthesia shivering in lower abdominal and lower limb surgeries: a randomized controlled comparison between paracetamol and dexamethasone.
    Esmat IM, Mohamed MM, Abdelaal WA, El-Hariri HM, et al · · 2021 · cited 6× · PMID 34717535 · DOI 10.1186/s12871-021-01483-7

Verify or expand the search:

Other trials of Paracetamol

Trials testing the same drug.

Other recruiting trials for Shivering

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03679065.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing